These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 18062974

  • 1. Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites.
    Scorza T, Grubb K, Cambos M, Santamaria C, Tshikudi Malu D, Spithill TW.
    Int J Parasitol; 2008 Jun; 38(7):819-27. PubMed ID: 18062974
    [Abstract] [Full Text] [Related]

  • 2. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A, Scorza T, Spithill TW, Smooker PM.
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [Abstract] [Full Text] [Related]

  • 3. A study on pathogenicity and mosquito transmission success in the rodent malaria parasite Plasmodium chabaudi adami.
    Gadsby N, Lawrence R, Carter R.
    Int J Parasitol; 2009 Feb; 39(3):347-54. PubMed ID: 18755194
    [Abstract] [Full Text] [Related]

  • 4. Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine.
    Scorza T, Grubb K, Smooker P, Rainczuk A, Proll D, Spithill TW.
    Infect Immun; 2005 May; 73(5):2974-85. PubMed ID: 15845504
    [Abstract] [Full Text] [Related]

  • 5. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
    Amante FH, Crewther PE, Anders RF, Good MF.
    J Immunol; 1997 Dec 01; 159(11):5535-44. PubMed ID: 9548494
    [Abstract] [Full Text] [Related]

  • 6. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL, Daly TM, Long CA.
    Exp Parasitol; 1999 Jan 01; 91(1):78-85. PubMed ID: 9920045
    [Abstract] [Full Text] [Related]

  • 7. Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors.
    Rainczuk A, Scorza T, Smooker PM, Spithill TW.
    Infect Immun; 2003 Aug 01; 71(8):4506-15. PubMed ID: 12874330
    [Abstract] [Full Text] [Related]

  • 8. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
    Cambos M, Bélanger B, Jacques A, Roulet A, Scorza T.
    Int J Parasitol; 2008 Feb 01; 38(2):229-38. PubMed ID: 17868677
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gamma delta T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria.
    van der Heyde HC, Elloso MM, Chang WL, Kaplan M, Manning DD, Weidanz WP.
    J Immunol; 1995 Apr 15; 154(8):3985-90. PubMed ID: 7706737
    [Abstract] [Full Text] [Related]

  • 12. Plasmodium chabaudi: immunogenicity of a highly antigenic glutamate-rich protein.
    Wiser MF, Giraldo LE, Schmitt-Wrede HP, Wunderlich F.
    Exp Parasitol; 1997 Jan 15; 85(1):43-54. PubMed ID: 9024201
    [Abstract] [Full Text] [Related]

  • 13. Antigen-specific, interleukin 2-propagated T lymphocytes confer resistance to a murine malarial parasite, Plasmodium chabaudi adami.
    Brake DA, Weidanz WP, Long CA.
    J Immunol; 1986 Jul 01; 137(1):347-52. PubMed ID: 2423609
    [Abstract] [Full Text] [Related]

  • 14. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
    Yanow SK, Purcell LA, Spithill TW.
    Mol Biochem Parasitol; 2006 Jul 01; 148(1):52-9. PubMed ID: 16597469
    [Abstract] [Full Text] [Related]

  • 15. Strain-specific immunity may drive adaptive polymorphism in the merozoite surface protein 1 of the rodent malaria parasite Plasmodium chabaudi.
    Cheesman S, Tanabe K, Sawai H, O'Mahony E, Carter R.
    Infect Genet Evol; 2009 Mar 01; 9(2):248-55. PubMed ID: 19121414
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exacerbation of Plasmodium chabaudi malaria in mice by depletion of TCR alpha beta+ T cells, but not TCR gamma delta+ T cells.
    Sayles PC, Rakhmilevich L.
    Immunology; 1996 Jan 01; 87(1):29-33. PubMed ID: 8666432
    [Abstract] [Full Text] [Related]

  • 18. Plasmodium chabaudi adami: use of the B-cell-deficient mouse to define possible mechanisms modulating parasitemia of chronic malaria.
    Weidanz WP, Batchelder JM, Flaherty P, LaFleur G, Wong C, van der Heyde HC.
    Exp Parasitol; 2005 Oct 01; 111(2):97-104. PubMed ID: 16087175
    [Abstract] [Full Text] [Related]

  • 19. Parasite-specific IgM plays a significant role in the protective immune response to asexual erythrocytic stage Plasmodium chabaudi AS infection.
    Couper KN, Phillips RS, Brombacher F, Alexander J.
    Parasite Immunol; 2005 May 01; 27(5):171-80. PubMed ID: 15987340
    [Abstract] [Full Text] [Related]

  • 20. Development of antimalaria immunity in mice lacking IFN-gamma receptor.
    Tsuji M, Miyahira Y, Nussenzweig RS, Aguet M, Reichel M, Zavala F.
    J Immunol; 1995 May 15; 154(10):5338-44. PubMed ID: 7537305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.